The Gladstone-UCSF Institute of Genomic Immunology is creating an ecosystem that brings together experts to develop transformative opportunities to harness the immune system to treat patients across a broad range of diseases.

In this inaugural symposium, scientists from around the world shared how they are using innovative technologies at the intersection of human immunology, genomics, CRISPR genome engineering, computational biology, and synthetic biology to answer key questions in human immunology and to repurpose the immune system for therapeutic benefit.

Introductory Remarks

Alex Marson, Director, Gladstone-UCSF Institute of Genomic Immunology 

Keynote: Transcriptional Regulation of CD8 T Cell Immunity to Pathogen and Tumors

Ananda Goldrath, UC San Diego

Deciphering the Role of Sex Hormones in Human Antiviral Immunity

Camila Rosat Consiglio, Karolinska Institutet

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Yapeng Su, Institute for Systems Biology

Dissecting Immune Mechanisms of Chronic Disease with Single Cell Genomic Technologies

Aleksandra Deczkowska,Weizmann Institute of Science

Lineage Tracing Reveals the Pro-tumorigenic Niche Role of Tissue Resident Macrophages in Early Lung Cancer Lesions

María Casanova-Acebes, Centro Nacional de Investigaciones Oncológicas

High Content Single-Cell Screens for Unraveling Gene Regulation Mechanisms in Cancer Immune Evasion

Pratiksha Thakore, Broad Institute

Keynote: The Sweet Side of CAR-T Cells

Avery Posey, Jr., Perelman School of Medicine, University of Pennsylvania

Want to Join the Team?

Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.

Explore Careers